AVITA Medical Gets CE Mark Approval for RECELL GO

MT Newswires Live
2025/09/15

AVITA Medical (RCEL) said Sunday that it has received CE Mark approval for its RECELL GO device, enabling it to commence sales in Europe and other CE-marked markets.

The company said that it will now roll out the device in select European countries, including Germany, Italy, and the UK, in collaboration with burn centers and clinical partners.

RECELL GO helps doctors use a small sample of a patient's skin to create a cell suspension that promotes healing in burns and wounds, it added.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10